Condition
Metastatic Alveolar Soft Part Sarcoma
Total Trials
4
Recruiting
2
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
4Total
P 1 (1)
P 2 (3)
Trial Status
Recruiting2
Terminated1
Active Not Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT06066138Phase 1Recruiting
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
NCT03141684Phase 2Active Not RecruitingPrimary
Testing Atezolizumab Alone or Atezolizumab Plus Bevacizumab in People With Advanced Alveolar Soft Part Sarcoma
NCT05333458Phase 2Recruiting
Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, The AXIOM Trial
NCT02113826Phase 2TerminatedPrimary
Pazopanib for Metastatic Alveolar Soft Part Sarcoma
Showing all 4 trials